4559:TYO
Zeria Pharmaceutical Co Ltd
1 903,00 ¥
arrow_upward
+0,26%(+5,00) 1 d.
5. okt., 15:30:00 GMT+9 · JPY
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4559…
Atvērt
1 901 ¥
Augsta
1 908 ¥
Zema
1 895 ¥
Tirgus kapitalizācija
95,38 mljrd.
Vid. apjoms
167,72 tūkst.
Apjoms
125,40 tūkst.
Dividende
2,57%
Ceturkšņa dividendes
12 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Cenas/peļņas attiecība
10,19
Augstākā 52 ned.
2 434 ¥
Zemākā 52 ned.
1 878 ¥
Peļņa uz vienu akciju
187 ¥
Apgrozībā esošās akcijas
50,11 milj.
Darbinieku skaits
2 tūkst.
Atvērt
1 901 ¥
Augsta
1 908 ¥
Zema
1 895 ¥
Tirgus kapitalizācija
95,38 mljrd.
Vid. apjoms
167,72 tūkst.
Apjoms
125,40 tūkst.
Dividende
2,57%
Ceturkšņa dividendes
12 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Cenas/peļņas attiecība
10,19
Augstākā 52 ned.
2 434 ¥
Zemākā 52 ned.
1 878 ¥
Peļņa uz vienu akciju
187 ¥
Apgrozībā esošās akcijas
50,11 milj.
Darbinieku skaits
2 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
PennLive.com
·
pirms 41 minūtes
Nasdaq-listed tech company names Pa. county as site for big data center campus in the works
Seeking Alpha
·
pirms 12 minūtēm
The 1-Minute Market Report October 4, 2026 (NYSEARCA:VOO)
PR Newswire UK
·
pirms 11 minūtēm
Solidion Technology (NASDAQ: STI) Remains Firm on Flux Power (NASDAQ: FLUX) Below Market Offer in Response to Flux Board Rejection
Reuters
·
pirms 2 stundām
Panmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end
Profils
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Par “Zeria Pharmaceutical Co Ltd”
ĢenerāldirektorsSachiaki Ibe
Darbinieki1,75 tūkst.
Dibināšanas datums1955. gada 22. dec.
Galvenais birojs-
Sektors-
Tīmekļa vietnezeria.co.jp